84-1036-86 p53 (Tumor Suppressor Protein, Oncogene Protein) 100ul P1001-27A

※お見積書はカートで印刷できます

冷凍 保管・搬送時に冷凍が必要な商品です。

特徴

  • p53 tumor suppressor gene mutations are one of the most common genetic alterations in human tumors, including lymphomas.
  • Altering or inactivating p53 by mutation or reaction with oncogenes or viruses may cause depletion of p53, or conversion of p53 from a tumor suppressor gene to a transforming oncogene.
  • The nuclear protein p53 is associated with cell transformation and proliferation, with definitive possibilities as a marker in malignant lymphoma progression.
  • p53's role in the multistep process leading to cancer is still being investigated, with an emphasis on its relation and control over additional tumor suppressors.
  • Expression correlates with poor prognosis in breast cancer.
  • In colonic cancer p53 expression seen in 47% of tumors and 9% of colonomas.
  • The p53 tumor suppressor protein plays a major role in cellular response to DNA damage and other genomic aberrations.
  • Activation of p53 can lead to either cell cycle arrest and DNA repair or apoptosis (1).
  • p53 is phosphorylated at multiple sites in vivo and by several different protein kinases in vitro (2,3).
  • DNA damage induces phosphorylation of p53 at Ser15 and Ser20 and leads to reduced interaction of p53 with its negative regulator, oncoprotein MDM2 (4).
  • MDM2 inhibits the accumulation of p53 by targeting it for ubiquitination and proteasomal degradation (6,7).
  • p53 can apparently be phosphorylated by ATM, ATR and DNA-PK at Ser15 and Ser37; the phosphorylations impair the ability of MDM2 to bind p53, promoting both the accumulation and functional activation of p53 in response to DNA damage (4,5).
  • Chk2 and Chk1 can phosphorylate p53 at Ser20, enhancing its tetramerization, stability and activity (8,9).
  • p53 is phosphorylated at Ser392 in vivo (11,12) and by CAK in vitro (12).
  • Applications: Suitable for use in Western Blot, Immunoprecipitation and Chromatin IP.
  • Other applications not tested.
  • Recommended Dilution:Western Blot: 1:1000.
  • Immunoprecipitation: 1:200Chromation IP: 1:100Optimal dilutions to be determined by the researcher.
  • Storage and Stability:May be stored at 4°C for short-term only.
  • Aliquot to avoid repeated freezing and thawing.
  • Store at -20°C.
  • Aliquots are stable for 12 months after receipt.
  • For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

仕様

  • Size:100ul
  • Host:rabbit
  • Source Antibody:human
  • Grade:Affinity Purified
  • Purity:Purified by Protein A and peptide affinity chromatography.
  • Form:Supplied as a liquid in 10mM HEPES, pH 7.5, 150mM sodium chloride, 0.1mg/ml BSA, 50% glycerol. No preservative added.
  • Specificity:Recognizes total levels of endogenous p53 protein (Mr 53kD). Does not crossreact with other p53-related proteins. Species Crossreactivity: Human, monkey, and rat.
  • Isotype:IgG
  • Calc Applications Abbrev:E IC IP WB
  • Calc Crossreactivity:Hu Mk Rt
  • Immunogen:MBP-p53 fusion protein.
  • Shelf Life:1year
  • Swiss Prot Number:P04637
  • EU Commodity Code:30021010
  • この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
  • 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
  • 【試薬に関するお問合せ】
  • アズワン株式会社 試薬・プロセス材料グループ
  • TEL:06-6447-8641
  • FAX:06-6447-8642
  • E-mail:[email protected]
アズワン品番
84-1036-86
型番
P1001-27A
入り数
1個
標準価格
199,000円(税抜)
WEB価格
アズワン在庫 [?]
数量

※お気に入り機能はログイン後にご利用いただけます

よくあるご質問

よくあるご質問(FAQ)

掲載カタログ情報

掲載カタログ名 掲載ページ

次の商品を登録しました。

商品計:

お買い物を続ける カートを見る